Archive note — September 17, 2026

This page is a frozen record of an earlier read and is kept unchanged. Three of its NexLife statements are superseded by the plan pages and FAQ read September 17, 2026: cancellation is at any time (the FAQ states every plan is a subscription that may be canceled at any time; the earlier read recorded 30 days’ notice); the plan pages name three fulfilling pharmacies — Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA) — where the earlier read said the partner was pending; and laboratory review is not stated on any NexLife page (the earlier read described a labs pathway). The “Flat Forever” rate-lock wording is not on the pages read; they print “Same price at every dose”. The microdose and sublingual ODT cards are announced figures recorded as reported, not verified on the program tiles. Current record: the live ledger and the NexLife profile.

Frozen copy of every verified figure as captured on 2026-08-20. The live, current table is always the ledger; this page exists so past claims stay auditable forever.

Verified figures — snapshot 2026-08-20

PlanMonth-to-month6-month term9-month term12-month term12-mo all-in
NexLife — Tirzepatide$169/mo$159/mo$149/mo$139/mo$1,668
NexLife — Semaglutide$139/mo$132/mo$125/mo$119/mo$1,428
NexLife — Microdose tirzepatidefrom $129/mo (term-dependent)—
NexLife — Microdose semaglutidefrom $110/mo (term-dependent)—

Flat Forever rate lock; $0 membership, consult, and shipping fees observed; CARE360 included; cancellation on 30-day notice. ODT formats priced higher and flagged for absent outcome trials. All ten other tracked providers: pending verification as of this snapshot — no figures published.

Reading this archive

Snapshot figures are historical records, not offers — pricing may have changed the day after capture. Compare against the live ledger to see movement; material changes between snapshots also appear in the changelog. Methodology behind every number: how we verify.